ESMO Guidance for Reporting Oncology real-World evidence (GROW)

•Real-world evidence in oncology is evolving rapidly with many particularities.•This guidance provides key recommendations for reporting real-world evidence studies in oncology.•Recommendations are based on a review of current evidence and the authors’ collective expert opinion.•Authors are a multid...

Full description

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 34; no. 12; pp. 1097 - 1112
Main Authors Castelo-Branco, L., Pellat, A., Martins-Branco, D., Valachis, A., Derksen, J.W.G., Suijkerbuijk, K.P.M., Dafni, U., Dellaporta, T., Vogel, A., Prelaj, A., Groenwold, R.H.H., Martins, H., Stahel, R., Bliss, J., Kather, J., Ribelles, N., Perrone, F., Hall, P.S., Dienstmann, R., Booth, C.M., Pentheroudakis, G., Delaloge, S., Koopman, M.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2023
Subjects
ESMO-GROW
guidance
Humans
Medical Oncology
observational studies
oncology
real-world data
real-world evidence
real-world data
real-world evidence
observational studies
guidance
ESMO-GROW
oncology
Online AccessGet full text

Cover

More Information
Summary:•Real-world evidence in oncology is evolving rapidly with many particularities.•This guidance provides key recommendations for reporting real-world evidence studies in oncology.•Recommendations are based on a review of current evidence and the authors’ collective expert opinion.•Authors are a multidisciplinary group of experts from different institutions and countries.•Guidance is provided for full article development, including title, introduction, methods, results, discussion, conclusion.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
ISSN:0923-7534
1569-8041
1569-8041
DOI:10.1016/j.annonc.2023.10.001